A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel. [electronic resource]
Producer: 20080908Description: 4836-42 p. digitalISSN:- 1078-0432
- Administration, Oral
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Benzenesulfonates -- administration & dosage
- Biopsy
- Carboplatin -- administration & dosage
- Female
- Humans
- Male
- Maximum Tolerated Dose
- Middle Aged
- Niacinamide -- analogs & derivatives
- Paclitaxel -- administration & dosage
- Phenylurea Compounds
- Pyridines -- administration & dosage
- Sorafenib
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.